# ÙØ§Ø² Ø¨Ø¹Ø¯ÛŒ: Ø¢Ø²Ù…Ø§ÛŒØ´Ø§Øª Non-IID
## Next Phase: Non-IID Experiments Plan

**ğŸ“… Planned Start:** Ù¾Ø³ Ø§Ø² ØªÚ©Ù…ÛŒÙ„ CIFAR-10  
**ğŸ¯ Goal:** Ù…Ù‚Ø§ÛŒØ³Ù‡ IID vs Non-IID attack detection  
**â±ï¸ Timeline:** 2-3 Ø³Ø§Ø¹Øª Ø¨Ø±Ø§ÛŒ 3 datasets  

---

## ğŸ“Š **ÙØ§Ø² 1: IID Results (Ø¯Ø± Ø­Ø§Ù„ ØªÚ©Ù…ÛŒÙ„)**

### âœ… **Completed:**
- ğŸ§  **Alzheimer:** 75% best precision âœ…
- ğŸ”¢ **MNIST:** 69% best precision âœ…  

### ğŸŸ¡ **In Progress:**
- ğŸ–¼ï¸ **CIFAR-10:** Testing... (~20 minutes remaining)

---

## ğŸš€ **ÙØ§Ø² 2: Non-IID Experiments (Next)**

### **Phase 2A: Non-IID Configuration**
```python
NON_IID_CONFIG = {
    'data_distribution': 'non_iid',
    'heterogeneity_level': 0.7,  # 70% non-IID
    'classes_per_client': 2,     # Ù…Ø­Ø¯ÙˆØ¯ Ú©Ø±Ø¯Ù† Ú©Ù„Ø§Ø³â€ŒÙ‡Ø§
    'alpha_dirichlet': 0.1,      # Ø´Ø¯Øª non-IID
}
```

### **Phase 2B: Datasets & Timeline**
| Dataset | Model | Priority | Est. Time | Expected Challenge |
|---------|-------|----------|-----------|-------------------|
| **MNIST** | CNN | High | 30 min | Easier baseline |
| **Alzheimer** | ResNet18 | High | 45 min | Medical critical |
| **CIFAR-10** | ResNet18 | Medium | 60 min | Most complex |

### **Phase 2C: Research Questions**
1. ğŸ“‰ **Performance Degradation:** Non-IID vs IID Ú©ÛŒÙÛŒØª
2. ğŸ¯ **Attack Detection:** Ø¢ÛŒØ§ Non-IID detection Ø±Ø§ Ø³Ø®Øªâ€ŒØªØ± Ù…ÛŒâ€ŒÚ©Ù†Ø¯ØŸ
3. ğŸ§  **Model Robustness:** Ú©Ø¯Ø§Ù… dataset Ù…Ù‚Ø§ÙˆÙ…â€ŒØªØ± Ø§Ø³ØªØŸ
4. ğŸ“Š **Comparison Analysis:** Ø¬Ø¯ÙˆÙ„ Ù…Ù‚Ø§ÛŒØ³Ù‡â€ŒØ§ÛŒ IID/Non-IID

---

## ğŸ“‹ **Configuration Strategy:**

### **Memory-Optimized Settings:**
```python
# Base configuration for all Non-IID tests
GLOBAL_EPOCHS = 4         # Ù…ØªÙˆØ³Ø· Ø¨Ø±Ø§ÛŒ Ú©ÛŒÙÛŒØª
LOCAL_EPOCHS_CLIENT = 4   
VAE_EPOCHS = 15          # Ú©Ø§ÙÛŒ Ø¨Ø±Ø§ÛŒ detection
BATCH_SIZE = 16          # memory safe
```

### **Priority Attack Types:**
1. ğŸ¯ **Partial Scaling** - Ù…Ø¹Ù…ÙˆÙ„Ø§ Ø¨Ù‡ØªØ±ÛŒÙ† detection
2. ğŸ”¥ **Noise Attack** - Ù‚ÙˆÛŒ Ø¯Ø± IID
3. ğŸŒªï¸ **Sign Flipping** - Ø§Ø³ØªØ§Ù†Ø¯Ø§Ø±Ø¯

---

## ğŸ¯ **Expected Outcomes:**

### **Hypothesis:**
- ğŸ“‰ **Detection precision Ú©Ø§Ù‡Ø´:** 10-20% Ø¯Ø± Non-IID
- ğŸ“Š **Alzheimer resilient:** medical data Ù…Ù‚Ø§ÙˆÙ…â€ŒØªØ±
- ğŸ”¢ **MNIST moderate impact:** benchmark data
- ğŸ–¼ï¸ **CIFAR-10 significant drop:** complex visual data

### **Success Criteria:**
- âœ… **50%+ precision** Ø¯Ø± Non-IID (vs 60-75% Ø¯Ø± IID)
- âœ… **Accuracy >90%** Ø­ÙØ¸ Ø´ÙˆØ¯
- âœ… **Progressive learning** Ù‡Ù…Ú†Ù†Ø§Ù† Ù…Ø´Ø§Ù‡Ø¯Ù‡ Ø´ÙˆØ¯
- âœ… **Reproducible results** Ø¨Ø§ documentation

---

## ğŸ“Š **Literature Comparison Ready:**

### **Phase 3: Comparison with 3 Papers**
1. ğŸ“„ **FedAvg baseline** (McMahan et al.)
2. ğŸ“„ **Byzantine-robust aggregation** (Blanchard et al.)  
3. ğŸ“„ **Recent FL attack detection** (2023-2024 papers)

### **Metrics for Comparison:**
- Detection Precision/Recall/F1
- Model Accuracy preservation  
- Computational overhead
- Scalability to client numbers

---

## â° **Timeline Summary:**

```
Phase 1 (IID): [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–“] 95% (CIFAR-10 finishing)
Phase 2 (Non-IID): [â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘] 0% (Ready to start)  
Phase 3 (Comparison): [â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘] 0% (Planned)

Total ETA: ~4 hours Ù„Ù„Ù…Ø±Ø§Ø­Ù„ 2-3
```

---

## ğŸ”„ **Ready to Execute:**

**Once CIFAR-10 completes:**
1. âœ… Update complete IID table
2. ğŸš€ Start Non-IID MNIST (quickest)  
3. ğŸ“Š Generate comparison plots
4. ğŸ“„ Finalize paper-ready results

**All configurations prepared and tested!** ğŸ‰ 